Urolog. pro Praxi, 2003; 1: 11-13

Současný stav léčby Peyronieho choroby

MUDr. Vladimír Kubíček CSc1,2
1 Centrum andrologické péče, České Budějovice, Centrum reprodukční medicíny GEST, Praha
2 Centrum andrologické péče, České Budějovice

Keywords: morbus Peyronie, pharmacotherapy, principle of drug effect, efficacy of therapy.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubíček V. Současný stav léčby Peyronieho choroby. Urol. praxi. 2003;4(1):11-13.

Plastická indurace penisu (morbus Peyronie) je onemocnění, které postihuje muže nejčastěji ve věku od třiceti let výše. S věkem jeho četnost stoupá. Nemocnému způsobuje často značné fyzické i psychické utrpení. Léčba vyžaduje trpělivost pacienta i lékaře, znalosti o limitech účinnosti jednotlivých léčebných metod a umění správné indikace léčby u konkrétního pacienta. Článek je zaměřen zejména na medikamentózní možnosti terapie morbus Peyronie, zmiňuje také možnosti fyzikální a operační léčby.

CURRENT STATE OF THERAPY OF PEYRONIE´S DISEASE

Plastic penile induration (morbus Peyronie) is a disease occurring in men from age of 30 and higher. Its prevalence rises with age. Patients often suffer physically and emotionally. Treatment requires patience both from a physician and a patient, knowledge about limitations of particular therapeutic method and art of proper indications to treat an individual patient. The paper gives attention especially to pharmacotherapy of morbus Peyronie, possibilities of physical and surgical therapy are mentioned as well.

Centrum andrologické péče, České Budějovice

GEST - Centrum reprodukční medicíny, Praha

Download citation

References

  1. Devine CJ, et al. A working model for the genesis of Peyronie´s disease derived from its pathobiology. J Urol 1988, 139 (part 2): 286 A, abstract 495. Go to PubMed...
  2. Scott WW, et al. A new concept in the treatment of Peyronie´s disease. South Med J 1948, 41: 173-177. Go to original source... Go to PubMed...
  3. Zarafonetis CJD, Horrax TM. Treatment of Peyronies´s disease with POTABA. J Urol 1959, 81: 770-772. Go to original source... Go to PubMed...
  4. Ralph DJ, et al. The treatment of Peyronie´s disease with tamoxifen. Br J Urol, 1992, 70: 648-651. Go to original source... Go to PubMed...
  5. Akkus E, Carrier S, Rehman J, et al. Is colchicine effective in Peyronie´s disease? A pilot study. Urology 1994, 44: 291-295. Go to original source... Go to PubMed...
  6. Kelami A. Classification of congenital and acquired penile deviation. Urol Int 1983, 38: 229-233. Go to original source... Go to PubMed...
  7. Primus G. Orgotein in the treatment of plastic induration of the penis (Peyronie´s disease). Int Urol Nephrol 1993, 25: 169-172. Go to PubMed...
  8. Levine LA, et al. Intralesional verapamil injection for the treatment of Peyronie´s disease. J Urol, 1994, 151: 1522-1524. Go to original source... Go to PubMed...
  9. Duncan MR, Berman B, Nseyo UO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie´s disease fibroblasts by interpherons-alpha, -beta, -gamma. Scand. J Urol Neprol. 1991, 25: 89-94. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.